Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Candesartan 8mg tablets
0205052C0AAACAC
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | 456,944 |
|
Candesartan 4mg tablets
0205052C0AAABAB
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | 377,416 |
|
Candesartan 16mg tablets
0205052C0AAADAD
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | 375,557 |
|
Candesartan 32mg tablets
0205052C0AAAHAH
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | 246,906 |
|
Candesartan 2mg tablets
0205052C0AAAAAA
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | 171,355 |
|
Candesartan 4mg/5ml oral liquid
0205052C0AAAIAI
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | 6 |
|
Candesartan 8mg/5ml oral liquid
0205052C0AAAJAJ
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | 1 |
|
Candesartan 16mg/5ml oral solution
0205052C0AAAKAK
|
Candesartan cilexetil | Candesartan cilexetil | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.